Antimalarial Agents: Design, Synthesis and Biological Evaluation
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (1 May 2020) | Viewed by 11365
Special Issue Editor
Special Issue Information
Dear Colleagues,
Malaria is still a crucial problem worldwide, in spite of the significant research progress made. A new vaccine that doubtlessly will save lives is now being implemented in several countries, but this will not be enough to eliminate the disease in many regions. Therefore, newer vaccines that might overcome the deficiencies of the one currently available are years away. Policy changes regarding the use of drug combinations, especially artemisinin combination therapies (ACTs), as well as implementation of these policies have swept through much of the malarious world, but resistance has emerged against these drugs. Thus, the discovery and development of new drugs that overcome the mechanisms of resistance to the currently used antimalarial therapies remain a necessity until we actually accomplish the worldwide eradication of the various human malaria parasites. This Special Issue is intended to allow researchers to describe efforts toward discovering and developing new antimalarial drugs as well as new approaches to overcome resistance to the existing drugs.
Prof. David H. Peyton
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- malaria
- falciparum
- vivax
- plasmodium
- drug resistance
- resistance
- clearance rate
- k13 gene
- kelch
- transmission
- PfCRT
- transporter
- drug discovery
- drug resistance
- drug development
- drug metabolism
